OPTIPAC 60 REFOBACIN BONE CEMENT R 4711500396-1

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a foreign,study report with the FDA on 2020-01-08 for OPTIPAC 60 REFOBACIN BONE CEMENT R 4711500396-1 manufactured by Biomet France S.a.r.l..

Event Text Entries

[174101637] (b)(4). Report source, foreign: event occurred in (b)(6). Medical product : cpt hip system femoral stem 12/14 neck taper standard offset size 1 130mm stem length, reference 00811400100, lot 63735436, investigated in (b)(4). Versys hip system femoral head 12:14 taper 22mm diameter +3. 0 neck length, reference (b)(4), batch 63677745, investigated in (b)(4). Avantage cemented acetabular cup size 48, reference (b)(4), batch 0001105980, investigated in (b)(4). Advantage cemented inlay s48, reference(b)(4), batch 0001102705 investigated in (b)(4). Optipac-s 60 refobacin bone cement r, reference (b)(4), batch b708c05355, investigated in (b)(4). The device was not returned to the manufacturer. Therefore it could not be analyzed and the event couldn't be confirmed. The review of the device manufacturing quality record indicates that 926 products optipac-s 60 refobacin bone cement r, reference (b)(4), batch a710b05615 were manufactured on 16th march 2017. The device manufacturing quality record indicates that the released product met all requirements to perform as intended. No non conformity or deviation was observed which could be linked to the event described in the complaint. Within one year, only the current complaint has been recorded for optipac-s 60 refobacin bone cement r, reference (b)(4), batch a710b05615 regarding a dislocation. According to available data, the exact root cause can? T be determined. This complaint could be reopened if further information is received later.
Patient Sequence No: 1, Text Type: N, H10


[174101638] It was reported that an initial left total hip arthroplasty was performed with implantation of an advantage cemented shell? 48mm, advantage inlay s48, optipac-s 60 refobacin bone cement lot a710b05615 and lot b708c05355, femoral stem 12/14 and femoral head sterile 12/14 on (b)(6) 2017. Subsequently, the patient was revised on (b)(6) 2018 due to recurrent dislocations, instability, and impingement. During the revision, a hematoma was noted as well as an absent posterior joint capsule. The advantage cemented shell? 48mm was left in place. The stem and femoral head were replaced with a competitor product, and the bearing was replaced by the advantage inlay s48 / 28. This report is a split of the (b)(4). The initial medwatch report number 3006946279-2019-00380 was submitted on august, 30 2019 and was common to the cup, the bearing and the two optipac. This follow up report provide the investigation for the optipac batch a710b05615.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3006946279-2019-00546
MDR Report Key9563172
Report SourceFOREIGN,STUDY
Date Received2020-01-08
Date of Report2019-12-11
Date of Event2018-07-02
Date Mfgr Received2019-11-19
Device Manufacturer Date2017-03-16
Date Added to Maude2020-01-08
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMS. CHRISTINA ARNT
Manufacturer Street56 E. BELL DR.
Manufacturer CityWARSAW IN 46582
Manufacturer CountryUS
Manufacturer Postal46582
Manufacturer Phone5745273773
Manufacturer G1BIOMET FRANCE S.A.R.L.
Manufacturer StreetPLATEAU DE LAUTAGNE BP75
Manufacturer CityVALENCE CEDEX 26903
Manufacturer CountryFR
Manufacturer Postal Code26903
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameOPTIPAC 60 REFOBACIN BONE CEMENT R
Generic NameBONE CEMENT, ANTIBIOTIC
Product CodeMBB
Date Received2020-01-08
Catalog Number4711500396-1
Lot NumberA710B05615
Device Expiration Date2018-08-31
OperatorLAY USER/PATIENT
Device AvailabilityN
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerBIOMET FRANCE S.A.R.L.
Manufacturer AddressPLATEAU DE LAUTAGNE BP75 VALENCE CEDEX 26903 FR 26903


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Required No Informationntervention 2020-01-08

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.